Literature DB >> 2569164

Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.

J Sap1, A Muñoz, J Schmitt, H Stunnenberg, B Vennström.   

Abstract

Several recent observations, such as the identification of the cellular homologue of the v-erb-A oncogene as a thyroid-hormone receptor, have strongly implicated nuclear oncogenes in transcriptional control mechanisms. The v-erb-A oncogene blocks the differentiation of erythroid cells, and changes the growth requirements of fibroblasts and erythroblasts. Mutations in v-erb-A protein have led to the loss of its affinity for thyroid hormones but do not affect its DNA-binding ability, a property required for biological activity. We report here the identification of a novel thyroid-hormone response element (TRE) in the long terminal repeat of Moloney murine leukaemia virus that binds the c-erb-A-alpha protein. The v-erb-A protein abolishes the responsiveness of this TRE to thyroid hormone, although it has a lower affinity than the normal receptor for the TRE. The data indicate that overexpressed v-erb-A protein negatively interferes with normal transcriptional-control mechanisms, and that amino-acid substitutions have altered its DNA-binding properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569164     DOI: 10.1038/340242a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  111 in total

1.  In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation.

Authors:  M K Kim; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex.

Authors:  Z Yang; S H Hong; M L Privalsky
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

3.  The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II).

Authors:  Y Zhou; W Gross; S H Hong; M L Privalsky
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

Review 4.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

5.  Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP.

Authors:  M O Bergot; M J Diaz-Guerra; N Puzenat; M Raymondjean; A Kahn
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

6.  Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.

Authors:  J Bigler; W Hokanson; R N Eisenman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 7.  Nuclear thyroid hormone receptors.

Authors:  M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

8.  The C'-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity.

Authors:  J M Holloway; C K Glass; S Adler; C A Nelson; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

10.  Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB.

Authors:  C W Wong; M L Privalsky
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.